Search

For people with cancer of unknown primary, MSK pathologists and medical oncologists are working on better ways to determine the likely primary site of disease.

… At Memorial Sloan Kettering, we are committed to learning how to better diagnose, treat, and support people with cancer of unknown primary. MSK researchers are leading promising new studies to identify therapeutic biomarkers (genetic mutations or other characteristics of a cell that promote tumor growth

Learn what Zepbound, Wegovy, Ozempic and other weight loss drugs mean for cancer risk and treatment, from an expert at MSK.

… Tuesday, March 10, 2026 Ozempic, Zepbound, Wegovy, and related weight loss drugs have become some of the world’s most talked about medications in a remarkably short time. A growing body of research suggests these drugs may also be an important tool in reducing cancer related to obesity and higher levels

Discover how microbiome research is revealing the role that bacteria play in cancer treatment.

… Thursday, August 11, 2016 Summary Studies that analyze the microbiome — the community of organisms that live in the body — in cancer patients are revealing new findings about the connection between bacteria and health in cancer patients. Highlights One study has shown how microbes may trigger colitis

… Search our virtual library of educational resources and health information, including written resources, videos, and online programs.

… Job Title Senior Research Scientist Degree MD Email [email protected]

For men with inherited mutations in BRCA1 and BRCA2, a new program at MSK provides a “one-stop shop” for highly personalized cancer screening and surveillance.

… Thursday, June 16, 2022 Perhaps the best known of all the cancer predisposition genes are inherited mutations in the genes BRCA1 and BRCA2 . They were originally associated with an increased risk of breast and ovarian cancers . Later studies revealed they also raised the risk of prostate and pancreatic

… Job Title Genetic Counselor, Peter MacCallum Cancer Institute, Australia Degree PhD Start Year 1997 End Year 1999 Email [email protected]

Researchers discover that a subset of lung adenocarcinomas are aggressive because of mutations that allow them to block ferroptosis, a type of cell death.

… Tuesday, December 1, 2020 Summary An MSK team has found that a particular subset of lung adenocarcinomas is aggressive due to a combination of two mutations that allow them to block ferroptosis, a type of cell death. Targeted therapies are currently available for about one-third of people with lung adenocarcinoma

BRCA1 and BRCA2 are not the only genes associated with an increased risk of breast cancer.

… BRCA1 and BRCA2 genes are the most well-known genes associated with breast cancer , but other genes have been identified as well. Depending on an individual’s personal and family history, multigene panel genetic testing may be used to evaluate other breast cancer–associated genes. Known Genetic Mutations

Learn about the symptoms of pancreatic cancer, such as abdominal pain and nausea.

… Learn about the symptoms of pancreatic cancer, including abdominal pain, nausea, and more. What are the signs and symptoms of pancreas cancer? So pancreas cancer’s an insidious process, and there aren’t any signs or symptoms that speak specifically to this disease in that they can represent a variety